Cargando…

Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus

Considering that counting the percentage of CD4 T lymphocytes can add prognostic information regarding patients infected with HIV, the aim of this study was to evaluate the percentage values of CD4+ T lymphocytes from 81 patients determined by flow cytometry and estimated by flow cytometry in conjun...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalva Borato, Danielle Cristyane, Carraro, Emerson, Weber Ribas, Sônia Regina, Kalva-Filho, Carlos Augusto, Rebuglio Vellosa, José Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515902/
https://www.ncbi.nlm.nih.gov/pubmed/23251108
http://dx.doi.org/10.1100/2012/906873
_version_ 1782252241945624576
author Kalva Borato, Danielle Cristyane
Carraro, Emerson
Weber Ribas, Sônia Regina
Kalva-Filho, Carlos Augusto
Rebuglio Vellosa, José Carlos
author_facet Kalva Borato, Danielle Cristyane
Carraro, Emerson
Weber Ribas, Sônia Regina
Kalva-Filho, Carlos Augusto
Rebuglio Vellosa, José Carlos
author_sort Kalva Borato, Danielle Cristyane
collection PubMed
description Considering that counting the percentage of CD4 T lymphocytes can add prognostic information regarding patients infected with HIV, the aim of this study was to evaluate the percentage values of CD4+ T lymphocytes from 81 patients determined by flow cytometry and estimated by flow cytometry in conjunction with a hematology counter. Means were compared through the Student's t-test. Pearson's correlation was determined, and the agreement between results was tested by Bland-Altman. The level of significance was P < 0.05. It was found a significantly higher mean difference between the relative values of CD4+ T lymphocytes to the hematologic counter (P < 0.05), for all strata studied. Positive and significant correlations (P < 0.01) were found between the strata CD4 < 200 cells/mL (r = 0.93), between 200 and 500 cells/mL (r = 0.65), and >500 cells/mL (r = 0.81). The limits of agreement were 1.0 ± 3.8% for the stratum of CD4 < 200 cells/mL, approximately 2.2 ± 13.5% for the stratum of CD4 between 200 and 500 cells/mL, and approximately 6.2 ± 20.4% for the stratum > 500 cells/mL. The differences in the percentages of CD4+ T lymphocytes obtained by different methodologies could lead to conflict when used in clinical decisions related to the treatment and care of people infected with HIV.
format Online
Article
Text
id pubmed-3515902
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Scientific World Journal
record_format MEDLINE/PubMed
spelling pubmed-35159022012-12-18 Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus Kalva Borato, Danielle Cristyane Carraro, Emerson Weber Ribas, Sônia Regina Kalva-Filho, Carlos Augusto Rebuglio Vellosa, José Carlos ScientificWorldJournal Clinical Study Considering that counting the percentage of CD4 T lymphocytes can add prognostic information regarding patients infected with HIV, the aim of this study was to evaluate the percentage values of CD4+ T lymphocytes from 81 patients determined by flow cytometry and estimated by flow cytometry in conjunction with a hematology counter. Means were compared through the Student's t-test. Pearson's correlation was determined, and the agreement between results was tested by Bland-Altman. The level of significance was P < 0.05. It was found a significantly higher mean difference between the relative values of CD4+ T lymphocytes to the hematologic counter (P < 0.05), for all strata studied. Positive and significant correlations (P < 0.01) were found between the strata CD4 < 200 cells/mL (r = 0.93), between 200 and 500 cells/mL (r = 0.65), and >500 cells/mL (r = 0.81). The limits of agreement were 1.0 ± 3.8% for the stratum of CD4 < 200 cells/mL, approximately 2.2 ± 13.5% for the stratum of CD4 between 200 and 500 cells/mL, and approximately 6.2 ± 20.4% for the stratum > 500 cells/mL. The differences in the percentages of CD4+ T lymphocytes obtained by different methodologies could lead to conflict when used in clinical decisions related to the treatment and care of people infected with HIV. The Scientific World Journal 2012-11-28 /pmc/articles/PMC3515902/ /pubmed/23251108 http://dx.doi.org/10.1100/2012/906873 Text en Copyright © 2012 Danielle Cristyane Kalva Borato et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Kalva Borato, Danielle Cristyane
Carraro, Emerson
Weber Ribas, Sônia Regina
Kalva-Filho, Carlos Augusto
Rebuglio Vellosa, José Carlos
Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus
title Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus
title_full Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus
title_fullStr Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus
title_full_unstemmed Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus
title_short Comparison of Two Methodologies for CD4+ T Lymphocytes Relative Counting on Immune Monitoring of Patients with Human Immunodeficiency Virus
title_sort comparison of two methodologies for cd4+ t lymphocytes relative counting on immune monitoring of patients with human immunodeficiency virus
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515902/
https://www.ncbi.nlm.nih.gov/pubmed/23251108
http://dx.doi.org/10.1100/2012/906873
work_keys_str_mv AT kalvaboratodaniellecristyane comparisonoftwomethodologiesforcd4tlymphocytesrelativecountingonimmunemonitoringofpatientswithhumanimmunodeficiencyvirus
AT carraroemerson comparisonoftwomethodologiesforcd4tlymphocytesrelativecountingonimmunemonitoringofpatientswithhumanimmunodeficiencyvirus
AT weberribassoniaregina comparisonoftwomethodologiesforcd4tlymphocytesrelativecountingonimmunemonitoringofpatientswithhumanimmunodeficiencyvirus
AT kalvafilhocarlosaugusto comparisonoftwomethodologiesforcd4tlymphocytesrelativecountingonimmunemonitoringofpatientswithhumanimmunodeficiencyvirus
AT rebugliovellosajosecarlos comparisonoftwomethodologiesforcd4tlymphocytesrelativecountingonimmunemonitoringofpatientswithhumanimmunodeficiencyvirus